Latest Rheumatology Stories
Be Joint Smart to educate roughly 48,000 local residents with PsA about their disease PORTLAND, Ore., Nov.
- Four pivotal Phase III studies of secukinumab in psoriatic arthritis (PsA) and ankylosing spondylitis (AS) to be presented for the first time at ACR 2014 EAST HANOVER, N.J., Nov.
Expert from the University of California San Francisco, regarded as one the world's leading academic centers in health sciences, will lead a discussion on pulmonary fibrosis in scleroderma.
VANCOUVER, Nov. 5, 2014 /PRNewswire/ - Augurex Life Sciences Corp.
Consensus Paper Available at GoutEducation.org PITTSBURGH, Nov.
Payers Employ a Variety of Cost-Control Measures to Manage the Utilization of Premium-Priced RA Agents, According to Findings from Decision Resources Group BURLINGTON, Mass., Oct.
New endurance program unites psoriatic disease community and cycling enthusiasts to find a cure PORTLAND, Ore., Oct.
SCOTTSDALE, Ariz., Oct.
- A member of the swell-mob; a genteelly clad pickpocket. Sometimes mobsman.